Daily News Podcast

FDA approval for 2 HIV drugs


 

The FDA approves the once-daily oral drugs Delstrigo and Pifeltro for HIV-1 infection. Also today, emicizumab beats factor VIII prophylaxis by a wide margin, orodental issues are often associated with facial port-wine stains, and epilepsy often accompanies congenital Zika infections. Subscribe to the MDedge Daily News wherever you get your podcasts.
Amazon Alexa
Apple Podcasts
Spotify

Recommended Reading

Sleepio app tied to reducing insomnia, depression
MDedge Internal Medicine
5 digital HIPAA myths
MDedge Internal Medicine
Screen for cervical cancer based on age, risk
MDedge Internal Medicine
Is it time for PCPs to take over chronic HCV?
MDedge Internal Medicine
Rivaroxaban data abound at ESC 2018
MDedge Internal Medicine
New MI definition for infarction vs injury
MDedge Internal Medicine
Lorcaserin shows cardiovascular safety
MDedge Internal Medicine
Lung function decline linked to cardiovascular risk
MDedge Internal Medicine
ESC 2018 in review
MDedge Internal Medicine
Rivaroxaban beats aspirin for VTE
MDedge Internal Medicine